According to a recent study, omitting growth factor administration following stem cell transplantation results in fewer side effects and less and shorter hospitalization for multiple myeloma patients compared to those who do receive growth factors. In addition, the study authors found that there was little difference between the two groups in the repopulation of white blood cells following transplantation.

According to Dr. Morie Gertz, myeloma expert at the Mayo Clinic in Rochester, Minnesota and lead author of the study, the difference in the repopulation of white blood cells was not clinically significant. …